Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Q: The study could scratch one item off a long list of complications plaguing President Barack Obama’s launch of his sweeping health care law, also known as Obamacare, which kicked in January 1. About half of U.S. states have opted to expand Medicaid eligibility to poor Americans under the law, raising concerns those states could attract low-income people from elsewhere, increasing the burden on state budgets. “This is known as the welfare magnet hypothesis,” according to the study from the Harvard School of Public Health, which said its research into previous state medical aid expansions “found no evidence of significant migration effects.”  The Harvard study used U.S. migration data from 1998 to 2012 to focus on the impact of medical insurance expansions in Arizona, Maine, New York, and also Massachusetts - whose own health care reforms served as a model for the Affordable Care Act. “These results suggest that migration will not be a common way for people to obtain Medicaid coverage under the current expansion and that interstate migration is not likely to be a significant source of costs for states choosing to expand their programs,” according to the study. “Our findings are relevant for forecasting the cost and coverage consequences of states’ decisions about expanding Medicaid eligibility,” it said, noting four states - New Hampshire, Pennsylvania, Missouri, and Utah - are still considering whether to expand Medicaid under the law. Arguments in favor of expanding Medicaid eligibility have tended to focus on improving access to medical care for the poor and bringing in federal dollars to bolster states’ social programs, while counterarguments have focused on the potential unintended costs to state budgets. A joint Harvard-MIT study released last week focusing on Oregon’s expanded Medicaid program, for example, showed adults covered by Medicaid used emergency rooms 40 percent more than those in similar circumstances who are uninsured. MIT led another study in 2013 focusing on Oregon that showed “Medicaid coverage generated no significant improvements in measured physical health outcomes in the first 2 years” but “did increase use of health care services, raise rates of diabetes detection and management, lower rates of depression, and reduce financial strain.”  The latest Harvard findings come after a rocky start for the Affordable Care Act, which relies on a website that suffered repeated crashes, glitches, and security concerns that hampered enrollment. After some fixes, more than 2 million people have been able to enroll for coverage under the law, the most sweeping social program since the 1960s. President Obama has also been criticized for telling Americans they would be able to keep their old insurance plans under the new law if they wanted to - an assertion that turned out to be false in many cases. The law was passed in 2010 to help millions of uninsured and under-insured Americans, but Republicans have opposed the reform as an unwarranted expansion of the federal government and say it is too costly and eliminates healthcare choices for many.

A: Americans unlikely to move to get better Medicaid benefits: study.
****
Q: The company announced $4 million in grants and said it would support “drive through” testing at 22 hospitals. Hyundai said it would provide the tests, which have been developed by South Korea-based diagnostics company Seegene, to hospitals in cities including New Orleans, Chicago and Detroit. The COVID-19 pandemic has thrown the global auto industry into the worst tailspin since the 2008-2009 financial crisis, with consumer demand collapsing as governments have enforced lockdowns in China, Europe and the United States. Hyundai’s U.S. sales fell 43% in March due to the pandemic.

A: Hyundai to provide COVID 19 tests, 'drive through' testing support in U.S.
****
Q: Dr. Nelson Teich, an oncologist and health care consultant, took the job April 17 faced with the task of aligning the ministry’s actions with the president’s view that Brazil’s economy must not be destroyed by restrictions to control spread of the virus. Teich’s predecessor, Luiz Henrique Mandetta, also had rejected the use of chloroquine, which also had been touted by U.S. President Donald Trump as a treatment. Four government ministers who spoke after Teich’s resignation defended the idea of patients being allowed to use the drug if they want to, including Economy Minister Paulo Guedes and the Cabinet chief of staff, Gen. Walter Braga Netto. Officials say almost 15,000 people have died in Brazil from COVID-19, the disease caused by the coronavirus, though some experts say the figure is significantly higher due to insufficient testing. The peak of the crisis has yet to hit Latin America’s largest nation, experts say. Gen. Eduardo Pazuello, who had no health experience until he became the Health Ministry’s No. 2 official in April, will be the interim minister until Bolsonaro chooses a replacement. Brazilian media have said that Teich’s ability to do his job had been weakened by the appointment of dozens of military personnel to jobs in the ministry. “Life is made up of choices and today I decided to leave,” Teich told journalists in capital Brasilia. He did not explain why he left the job and refused to answer questions. Braga Netto, the Cabinet chief, said Teich left the job “for personal reasons.” Bolsonaro did not comment. Teich’s resignation came one day after Bolsonaro told business leaders in a videoconference he would ease rules for using chloroquine to treat people infected with the coronavirus. Teich has frequently called use of the drug “an uncertainty,” and this week warned of its side effects. The Health Ministry previously allowed chloroquine to be used in coronavirus cases only for patients hospitalized in serious condition. At Bolsonaro’s urging, the country’s Army Chemical and Pharmaceutical Laboratory boosted chloroquine production in late March. Researchers last month reported no benefit in a large analysis of the drug or a related substance, hydroxychloroquine, in U.S. hospitals for veterans. Last month, scientists in Brazil stopped part of a study of chloroquine after heart rhythm problems developed in one quarter of people given the higher of two doses being tested. Governors who have recommended quarantine measures and refrained from touting the drug’s unproven potential said Teich’s resignation reflects Bolsonaro’s failure to manage the pandemic. Rio de Janeiro Gov. Wilson Witzel, a former ally of Bolsonaro, said “no one can do serious work with interference in ministries.” “That is why governors and mayors need to lead the pandemic crisis, and not you, Mr. President,” Witzel said on Twitter. The governor of Ceara, one of Brazil’s most hard-hit states, said Teich’s exit “brings enormous insecurity and concern.” “It is unacceptable that in the face of this serious health crisis, the focus of the government is still on political and ideological discussions. That is an affront to the nation,” Camilo Santana said. On April 16, Bolsonaro fired Teich’s predecessor, Mandetta, who had become the embodiment of challenges to the president’s opposition to governors’ quarantine recommendations and restrictions on businesses. Bolsonaro was eager to resume economic activity and warned failure to do so would cause Brazil to descend into “chaos”. Teich took office pledging to balance health care concerns and the president’s economic worries. He did not openly challenge the president’s views, but did defend stay-at-home measures. Miguel Lago, executive director of Brazil’s non-profit Institute for Health Policy Studies, which advises public health officials, said Teich wasn’t able to build his own team, didn’t have Mandetta’s political strength and wasn’t willing to violate the scientific recommendations. “He clearly had limitations,” Lago said. “He would not challenge what has been consensus among the scientific community. He would never accept the chloroquine thing that Bolsonaro wanted him to do, to recommend publicly that chloroquine was a remedy to be used in the public health system.”  Hours after Teich left the job, the Health Ministry began listing figures on chloroquine distribution as part of its main charts about government initiatives against the pandemic, alongside intensive care unit beds, personal protection equipment, tests and flu vaccines. Risk consultancy Eurasia Group analyst Filipe Gruppelli Carvalho said that the Health Ministry’s capacity for ”an effective coordinating role looks to have dropped with Mandetta’s exit,” . “Ultimately, Teich’s dismissal reinforces our view of increasing risks from the government’s poor response to the pandemic, which could contribute to a weaker presidency and decline in support for Bolsonaro in the post-pandemic phase,” he said. The newspaper Folha de S.Paulo published an editorial after Teich’s exit saying Bolsonaro is trying to “put his own survival above state policies and national interest.” “The resignation of another health minister — in less than a month and during the most serious sanitary emergency of contemporary history — exposes the downfall of a president that doesnt’t even pretend to govern the country,” the newspaper said. “As if the economic and sanitary calamities were not enough, he turned himself into a crisis to be faced.” After Teich’s resignation was announced, pot-banging protests were heard in different regions of Sao Paulo and Rio de Janeiro. _____ Associated Press writers David Biller and Diane Jeantet in Rio de Janeiro contributed to this report.

A:
Brazil’s health minister resigns after one month on the job.
****